Skip to main content

Find Clinical Trials

Home
Conditions
Hypereosinophilic Syndrome

Clinical trial condition

Hypereosinophilic Syndrome

Explore clinical trials studying Hypereosinophilic Syndrome. Study availability and eligibility vary by location and protocol.

69 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Hypereosinophilic Syndrome trial results

Not Yet Recruiting

Nasal Inflammation Following Endotoxin Challenge in Patients With Asthma

NCT06270576

Conditions: Asthma, Asthma; Eosinophilic, Bronchial Diseases, +13 more
Locations: National Jewish Health Denver, Colorado, United States

View Trial Details

Not Yet Recruiting

Severe Eosinophilic Asthma Phenotypes During Childhood Have Various Origins

NCT05762627

Conditions: Asthma, Asthma in Children, Bronchial Diseases, +14 more
Locations: Allergy Department, Trousseau Hospital Paris, France

View Trial Details

Completed

Severe Asthma, MepolizumaB and Affect: SAMBA Study

NCT04680611

Conditions: Adjustment, Adjustment, Emotional, Anxiety, +27 more
Locations: Department of Respiratory Medicine, Aberdeen Royal Infirmary Aberdeen, Grampian, United Kingdom

Judit Varkonyi-Sepp Southampton, Hampshire, United Kingdom

Hull University Teaching Hospitals NHS Trust Hull, Yorkshire, United Kingdom

Pinderfields Hospital Wakefield, Yorkshire, United Kingdom

View Trial Details

Completed

Eosinophils Endotypes in Chronic Airway Inflammatory Diseases

NCT04187976

Conditions: Asthma, Bronchial Diseases, Chronic Sinusitis, +15 more
Locations: CHU Lille Lille, France

View Trial Details

Completed

A Real World Study to Capture Clinical and Patient Centered Outcomes in Adults With Severe Eosinophilic Asthma Treated With Benralizumab.

NCT05440656

Conditions: Asthma, Bronchial Diseases, Eosinophilia, +13 more
Locations: Research Site Alexandroupoli, Greece

Research Site Athens, Greece

Research Site Athens, Greece

Research Site Athens, Greece

View all 13 locations

View Trial Details

Completed

Changes in Gene Transcription and Immunophenotypes Following Mepolizumab Treatment for Asthma

NCT05002621

Conditions: Eosinophilia, Eosinophilic Asthma, Hematologic Diseases, +6 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Completed

Patient-Reported OUTcomes of Benralizumab in Real-World Use in Severe EosiNophilic Asthma Patients

NCT05603845

Conditions: Asthma, Bronchial Diseases, Eosinophilia, +13 more
Locations: Research Site Bogotá, Colombia

Research Site Bucaramanga, Colombia

Research Site Ibague, Colombia

Research Site Pereira, Colombia

View all 24 locations

View Trial Details

Completed

Efficacy of Mepolizumab in Polish Patients With Severe Eosinophilic Asthma

NCT05091385

Conditions: Asthma; Eosinophilic, Eosinophilia, Hematologic Diseases, +6 more
Locations: Medical University of Lodz, Dept. of Immunology and Allergy Lodz, Poland

View Trial Details

Completed

IL-13 Blockade and Airway Autoimmunity in Asthma

NCT05564078

Conditions: Airway Auto Immunity in Asthma, Asthma, Bronchial Diseases, +13 more
Locations: The Research Institute of St. Joe's Hamilton Hamilton, Ontario, Canada

View Trial Details

Completed

Treatment With Mepolizumab on Patients With Severe Refractory Eosinophilic Asthma

NCT05063981

Conditions: Asthma, Bronchial Diseases, Eosinophilia, +16 more
Locations: Istituti Clinici Scientifici Maugeri IRCCS Telese Terme, BN, Italy

Istituti Clinici Scientifici Maugeri IRCCS Tradate, Varese, Italy

View Trial Details